Cambridge Isotope Laboratories, Inc. (CIL) is the world’s leading producer of stable isotopes and stable isotope-labeled compounds, specializing in the process of labeling biochemical and organic compounds with highly enriched stable isotopes of carbon, hydrogen, nitrogen, and oxygen. These stable isotope-labeled compounds include amino acids, acylcarnitines, vitamins, steroids, nucleic acids, and other metabolites.
CIL also offers single- and multi-component mixtures of these compounds for ease of use. Utilizing stable isotope-labeled standards in clinical research and testing facilitates accurate and precise measurements. CIL also has cGMP capabilities; many substrates can be manufactured to Q7A compliance.